Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation
Pallab Kar, Vijay Kumar, Balachandar Vellingiri, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 40, Iss. 10, pp. 4532-4542
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Mucormycosis: An opportunistic pathogen during COVID-19
Mahalaxmi Iyer, Kaavya Jayaramayya, Dhivya Venkatesan, et al.
Environmental Research (2021) Vol. 201, pp. 111643-111643
Open Access | Times Cited: 181
Inhibition of the main protease of SARS-CoV-2 (Mpro) by repurposing/designing drug-like substances and utilizing nature’s toolbox of bioactive compounds
Io Antonopoulou, Eleftheria Sapountzaki, Ulrika Rova, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 1306-1344
Open Access | Times Cited: 69
Targeting COVID-19 (SARS-CoV-2) main protease through active phytocompounds of ayurvedic medicinal plants – Emblica officinalis (Amla), Phyllanthus niruri Linn. (Bhumi Amla) and Tinospora cordifolia (Giloy) – A molecular docking and simulation study
Selvakumar Murugesan, Sanjay Kottekad, Inchara Crasta, et al.
Computers in Biology and Medicine (2021) Vol. 136, pp. 104683-104683
Open Access | Times Cited: 93
A review on potential of natural products in the management of COVID-19
Rudra Chakravarti, Rajveer Singh, Arijit Ghosh, et al.
RSC Advances (2021) Vol. 11, Iss. 27, pp. 16711-16735
Open Access | Times Cited: 79
An evaluation on potential anti-oxidant and anti-inflammatory effects of Crocin
Sepideh Bastani, Vahid Vahedian, Mohsen Rashidi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113297-113297
Open Access | Times Cited: 61
Phytochemicals-based targeting RdRp and main protease of SARS-CoV-2 using docking and steered molecular dynamic simulation: A promising therapeutic approach for Tackling COVID-19
Arpana Parihar, Zannatul Ferdous Sonia, Farjana Akter, et al.
Computers in Biology and Medicine (2022) Vol. 145, pp. 105468-105468
Open Access | Times Cited: 53
Alkaloids as Potential Phytochemicals against SARS-CoV-2: Approaches to the Associated Pivotal Mechanisms
Mohammad Bagher Majnooni, Sajad Fakhri, Gholamreza Bahrami, et al.
Evidence-based Complementary and Alternative Medicine (2021) Vol. 2021, pp. 1-21
Open Access | Times Cited: 47
Natural product remedies for COVID-19: A focus on safety
Aitebiremen Gift Omokhua-Uyi, J. Van Staden
South African Journal of Botany (2021) Vol. 139, pp. 386-398
Open Access | Times Cited: 39
Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies
Mohitosh Biswas, Nares Sawajan, Thanyada Rungrotmongkol, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 22
Discovery of natural catechol derivatives as covalent SARS-CoV-2 3CLpro inhibitors
Feng Wang, Donglan Liu, Dingding Gao, et al.
International Journal of Biological Macromolecules (2024) Vol. 264, pp. 130377-130377
Closed Access | Times Cited: 4
Antibacterial and antioxidant potentials, detection of host origin compounds, and metabolic profiling of endophytic Bacillus spp. isolated from Rauvolfia serpentina (L.) Benth. ex Kurz
Rusi Lata, Surendra K. Gond
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Proposing a new anti-Covid-19 agent by using molecular docking and dynamics simulations
I Silva, Luís F. G. Martins, Julliane Yoneda
Brazilian Journal of Pharmaceutical Sciences (2025) Vol. 61
Open Access
Potential Nutraceuticals for COVID-19
Sayali Savant, Shraddha Srinivasan, Anil Kumar Kruthiventi
Nutrition and Dietary Supplements (2021) Vol. Volume 13, pp. 25-51
Open Access | Times Cited: 27
Novel Drug Design for Treatment of COVID-19: A Systematic Review of Preclinical Studies
Sarah Mousavi, Shima Zare, Mahmoud Mirzaei, et al.
Canadian Journal of Infectious Diseases and Medical Microbiology (2022) Vol. 2022, pp. 1-70
Open Access | Times Cited: 18
In vitro effect of Withania somnifera, AYUSH-64, and remdesivir on the activity of CYP-450 enzymes: Implications for possible herb−drug interactions in the management of COVID-19
Siva Swapna Kasarla, Swapnil Borse, Yashwant Kumar, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
Identification of Putative Cell‐entry‐inhibitory Peptides against SARS‐CoV‐2 from Edible Insects: An in silico Study
Fai‐Chu Wong, Joe‐Hui Ong, Tsun‐Thai Chai
eFood (2020) Vol. 1, Iss. 5, pp. 357-368
Open Access | Times Cited: 20
Structural Insight into the Binding of Cyanovirin-N with the Spike Glycoprotein, Mpro and PLpro of SARS-CoV-2: Protein–Protein Interactions, Dynamics Simulations and Free Energy Calculations
Devashan Naidoo, Pallab Kar, Ayan Roy, et al.
Molecules (2021) Vol. 26, Iss. 17, pp. 5114-5114
Open Access | Times Cited: 17
Screening of potent phytochemical inhibitors against SARS-CoV-2 protease and its two Asian mutants
Ijaz Muhammad, Noor Rahman, Gul-E-Nayab, et al.
Computers in Biology and Medicine (2021) Vol. 133, pp. 104362-104362
Open Access | Times Cited: 16
Computational profiling of natural compounds as promising inhibitors against the spike proteins of SARS‐CoV‐2 wild‐type and the variants of concern, viral cell‐entry process, and cytokine storm in COVID‐19
Pallab Kar, Md. Moshfekus Saleh‐E‐In, Nishika Jaishee, et al.
Journal of Cellular Biochemistry (2022) Vol. 123, Iss. 5, pp. 964-986
Open Access | Times Cited: 12
Inhibitory effects of selected isoquinoline alkaloids against main protease (Mpro) of SARS-CoV-2, in silico study
Morteza Sadeghi, Mehran Miroliaei
In Silico Pharmacology (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 12
Recent advances on the therapeutic potential with Ocimum species against COVID-19: A review
Riya Bhattacharya, Debajyoti Bose, Quratulain Maqsood, et al.
South African Journal of Botany (2023) Vol. 164, pp. 188-199
Closed Access | Times Cited: 6
Amomum tsao-ko essential oil, a novel anti-COVID-19 Omicron spike protein natural products: A computational study
Ju-Zhao Liu, Hong-Chang Lyu, Yujie Fu, et al.
Arabian Journal of Chemistry (2022) Vol. 15, Iss. 7, pp. 103916-103916
Open Access | Times Cited: 10
Structural elucidation and chemical characterization of underutilized fruit silverberry (Elaeagnus pyriformis) silver nanoparticles playing a dual role as anti-cancer agent by promoting apoptosis and inhibiting ABC transporters
Swarnendra Banerjee, Pallab Kar, Indrani Sarkar, et al.
South African Journal of Botany (2021) Vol. 145, pp. 243-257
Open Access | Times Cited: 13
The Potential of Natural Products in the Management of COVID-19
Mona M. Saber, Maha M. Salama, Osama A. Badary
Advances in experimental medicine and biology (2024), pp. 215-235
Closed Access | Times Cited: 1
Review from host and guest approach to new frontiers nutraceuticals in the era of COVID-19
Matteo Micucci, Silvia Gioacchini, Melissa Baggieri, et al.
Future Foods (2024) Vol. 9, pp. 100303-100303
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top